Search Results

Tipiracil HCl 50mg  | ≥99%

CSNpharm

Tipiracil HCl is an inhibitor of thymidine phosphorylase (TPase) with IC50 of 35 nM. It has been used in the combination therapy of metastatic colorectal cancer.

More Information Supplier Page

Tipiracil HCl 250mg  | ≥99%

CSNpharm

Tipiracil HCl is an inhibitor of thymidine phosphorylase (TPase) with IC50 of 35 nM. It has been used in the combination therapy of metastatic colorectal cancer.

More Information Supplier Page

Gatifloxacin HCl 5g  | ≥99%

CSNpharm

Gatifloxacin HCl is a fourth-generation fluoroquinolone antibiotic working by inhibiting the bacterial enzymes DNA gyrase and topoisomerase IV.

More Information Supplier Page

17-AAG 5mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 250mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 100mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page

17-AAG 10mg  | ≥98%

CSNpharm

17-AAG is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells.

More Information Supplier Page